These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10313642)

  • 1. Public health aspects of Down's syndrome (Mongolism).
    Stein ZA; Goldsmith R; Kline J; Margolis S; Sadow M; Zybert P
    Public Health Rev; 1975; 4(3-4):229-53. PubMed ID: 10313642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief reports decline of Down's syndrome after abortion reform in New York State.
    Hansen H
    Am J Ment Defic; 1978 Sep; 83(2):185-8. PubMed ID: 151507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.
    Khoshnood B; De Vigan C; Vodovar V; Goujard J; Goffinet F
    BJOG; 2004 May; 111(5):485-90. PubMed ID: 15104615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal screening for Down's syndrome.
    Wald NJ; Kennard A; Hackshaw A; McGuire A
    J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Down's syndrome in a pregnant population in Finland.
    Marttala J; Yliniemi O; Gissler M; Nieminen P; Ryynanen M
    Acta Obstet Gynecol Scand; 2010 May; 89(5):715-7. PubMed ID: 20218932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Variations in the prevalence of Down's syndrome in the French population between 1978 and 2005].
    Rousseau T; Amar E; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
    J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):290-6. PubMed ID: 20430534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second trimester screening for Down's syndrome: 7 years experience.
    Beaman JM; Goldie DJ
    J Med Screen; 2001; 8(3):128-31. PubMed ID: 11678551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The population prevalence of Down's syndrome in England and Wales in 2011.
    Wu J; Morris JK
    Eur J Hum Genet; 2013 Sep; 21(9):1016-9. PubMed ID: 23321618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proportions of Down's syndrome pregnancies detected prenatally in England and Wales from 1989 to 2004.
    Morris JK; Alberman E; Mutton D
    J Med Screen; 2006; 13(4):163-5. PubMed ID: 17217603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Down's syndrome in the Czech Republic 1961-1997].
    Sípek A; Gregor V; Horácek J; Chudobová M
    Ceska Gynekol; 1999 Jun; 64(3):173-9. PubMed ID: 10568048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of induced abortion on the incidence of Down's syndrome in Hawaii.
    Smith RG; Gardner RW; Steinhoff P; Chung CS; Palmore JA
    Fam Plann Perspect; 1980; 12(4):201-5. PubMed ID: 6449372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum screening in Ontario using the triple marker test.
    Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR
    J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.